Suppr超能文献

间接计算机辅助药物设计策略。

Strategies for indirect computer-aided drug design.

作者信息

Loew G H, Villar H O, Alkorta I

机构信息

Molecular Research Institute, Palo Alto, California 94304.

出版信息

Pharm Res. 1993 Apr;10(4):475-86. doi: 10.1023/a:1018977414572.

Abstract

This review is intended to describe some of the methods and procedures used for computer-aided drug design when the structure of the macromolecular target is unknown, as is the case for CNS active drugs. Strategies and methods used in computer-aided design of drugs in such instances must be "indirect," i.e., focusing on the characterization of the ligands themselves. This situation is different from one in which the three-dimensional structure of the macromolecular target for a drug is known, for example, for drugs that are enzyme inhibitors, allowing "direct" characterization of ligand-receptor interactions. Two qualitatively different "indirect" approaches are described here. One, called 2D-QSAR, is briefly reviewed. It is based on delineating regression relationships between a specified biological end point and properties of the compounds eliciting it. The other, based on pharmacophore development, constitutes the main part of this review. Several levels of pharmacophore development are described, which differ in the extent to which they encompass fundamental molecular properties that are determinants of receptor recognition and activation. The strengths and limitations of each procedure are discussed and illustrated by examples. Two methods for obtaining model receptor structures are then briefly described. Both rely on the prior success of the indirect methods in obtaining ligand properties that modulate receptor recognition and activation. These emerging capabilities have the potential to bridge the gap between indirect and direct methods of drug design, since, if successful, the design process can continue in a direct mode using explicit characterization of drug-receptor interactions. Strategies for hypothesis validation and use of hypothesis for drug design and discovery are also briefly reviewed. The final sections of this review describe specific computational tools such as molecular mechanics and quantum mechanical methods used to characterize and identify relevant molecular properties and indicate some areas for future development of computational chemistry methods that could increase its effectiveness in the design of novel drugs.

摘要

本综述旨在描述当大分子靶点结构未知时(如中枢神经系统活性药物的情况)用于计算机辅助药物设计的一些方法和程序。在这种情况下,计算机辅助药物设计中使用的策略和方法必须是“间接的”,即专注于配体本身的特性表征。这种情况与药物的大分子靶点三维结构已知的情况不同,例如对于酶抑制剂药物,可对配体 - 受体相互作用进行“直接”表征。本文描述了两种性质不同的“间接”方法。一种称为二维定量构效关系(2D - QSAR),将进行简要综述。它基于描绘特定生物学终点与引发该终点的化合物性质之间的回归关系。另一种基于药效团开发,是本综述的主要部分。描述了药效团开发的几个层次,它们在涵盖作为受体识别和激活决定因素的基本分子性质的程度上有所不同。讨论了每个程序的优缺点,并举例说明。然后简要描述了两种获得模型受体结构的方法。这两种方法都依赖于间接方法在获得调节受体识别和激活的配体性质方面的先前成功。这些新兴能力有可能弥合药物设计间接方法和直接方法之间的差距,因为如果成功,设计过程可以使用药物 - 受体相互作用的明确表征以直接模式继续。还简要综述了假设验证策略以及将假设用于药物设计和发现的方法。本综述的最后部分描述了用于表征和识别相关分子性质的特定计算工具,如分子力学和量子力学方法,并指出了计算化学方法未来可能提高其在新药设计中有效性的一些发展领域。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验